Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2022

Apr 1, 2022

284_dirs_2022-04-01_ad2275b1-ee89-4547-b513-f47e4a87737b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2022-03-31

Reporting Person: Coe Mary Ellen (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-31 Phantom Stock $ A 396.0999 Acquired Common Stock (396.0999) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10 Direct

Footnotes

F1: 1-for-1

F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3: Holdings include shares acquired in dividend reinvestment transactions.